baber/WOPTO huggingface dataset:
Patent ZA-200501753-B (ZA)
Title: Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent
Inventor: PELISSON ISABELLE
IPC: A61K/
Filed: 2005-03-01
Abstract: Topically applicable skin depigmenting compositions, suited for treatment of such hyperpigmentary disorders as melasma and chloasma, contain a thus effective amount of at least one skin depigmenting active agent, for example hydroquinone or 4-hydroxyanisole, in admixture with a depigmentation-accelerating amount of adapalene (6-[3-(1-adamantyl)-4-methoxyphenyl]-2-napthanoic acid), and optionally with at least one sunscreen, formulated into a topically applicable, physiologically acceptable medium therefor.
Patent ZA-200608169-B (ZA)
Title: Inhibiting reflux in a heated well of an in situ conversion system
Inventor: DAVID FAIRBANKS MICHAEL
IPC: E21B43/00
Filed: 2006-10-02
Abstract: Certain embodiments provide a heater. A heater device includes a skin effect component having at least one insulated electrical core conductor in electrical communication with an adjacent and substantially parallel, elongated ferromagnetic shape having a reduction and localization of the depth and width of the effective conductor path in the cross-section of the ferromagnetic wall; and, an inorganic ceramic insulation component.
Patent ZA-200708185-B (ZA)
Title: Liquid laundry detergent compositions with modified polyethyleneimine polymers and lipase enzyme
Inventor: FRANK SOUTER PHILIP
IPC: C11D/
Filed: 2007-09-25
Abstract: A liquid laundry detergent for improved grease and oil cleaning having a lipase enzyme, a modified polyethyleneimine polymer and a liquid carrier.
Patent ZA-202106381-B (ZA)
Title: Biological information handling
Inventor: VAN HYFTE DIRK
Filed: 2021-09-01
Abstract: In a first aspect, the present invention relates to a computer-implemented method for obtaining information on a biological entity which is based on at least one biological sequence, comprising: (a) providing a repository of fingerprint data strings for a biological sequence database, each fingerprint data string representing a characteristic biological subsequence made up of sequence units, each characteristic biological subsequence having in the biological sequence database a combinatory number which is lower than the total number of different sequence units available thereto, the combinatory number of a biological subsequence being defined as the number of different sequence units that appear in the biological sequence database as a consecutive sequence unit of the biological subsequence; (b) determining one or more fingerprint data strings which are representative for the biological entity; (c) searching a repository comprising information associated with the fingerprint data strings for information associated with the one or more representative fingerprint data strings; and (d) processing the information.
Patent ZA-202304081-B (ZA)
Title: Guar gum-based compound and preparation method thereof, zinc-sulfur separation inhibitor and zinc-sulfur flotation separation method, flocculant and application thereof
Inventor: LU LIANG
Filed: 2023-03-30
Abstract: The present application provides a guar gum-based compound and a preparation method thereof, a zinc-sulfur separation inhibitor and a zinc-sulfur flotation separation method, a flocculant and application thereof. The guar gum-based compound has a structural formula wherein R1-R9 independently represent hydrogen atoms or functional groups capable of interacting with metal ions; and at least one of R1‑R9 is not H. The preparation method of the guar gum-based compound comprises: reacting guar gum with a compound containing functional groups capable of interacting with metal ions to obtain the guar gum-based compound. The zinc-sulfur separation inhibitor comprises the guar gum-based compound. The zinc-sulfur flotation separation method comprises: adding the zinc-sulfur separation inhibitor into pulp for flotation. The flocculant comprises the guar gum-based compound. The application of the flocculant refers to application in mineral processing or wastewater treatment. The guar gum-based compound provided by the present application has excellent flocculation effect and biocompatibility, and convenient synthesis.
Patent GR-1004330-B (GR)
Title: Pharmaceutical dosage form for the delivery of organic nitrates
Inventor: FOTEINOS SPYRIDON
IPC: A61P9/10
Filed: 2002-10-14
Abstract: In the present invention, a pharmaceutical dosage form for the delivery of organic nitrate in patients is described. The dosage form is based on the use of a semipermeable membrane (2) which covers a tablet (1) which contains a combination of one or more organic nitrates with excipients. The membrane (2) determines the water input rate towards the inner tablet (1). The osmotic pressure that develops, drives the contents of the tablet to exit through a hole (5) on the membrane, with a specific and controlled rate, regardless of the conditions of the gastrointestinal tract. It is possible that an amount of the organic nitrates is also released immediately upon administration of the dosage form, from a layer (3) placed outside the semipermeable membrane (2). Thus, the organism is provided with organic nitrates as desired in order to achieve optimum therapeutic results. Lastly, it is possible to have an external protective layer (4) which provides protection, improves stability and a long life to the dosage form, and also facilitates administration to the patient.
Patent GR-1004569-B (GR)
Title: Composite step-marking tool used in stairs under construction
Inventor: TSOURMAS NIKOLAOS DIMITRIOU
IPC: E04F21/26
Filed: 2003-09-12
Abstract: composite tool designed for marking the position of steps on stairs under construction is disclosed. It is composed of a 20x30 cm angle having on both sides an engraved meter, and a spirit level, which is 6 cm wide and 2 cm deep and integral to the longer side of the angle.
Patent IN-188043-B (IN)
Inventor: CONEY MICHAEL WILLOUGHBY ESSEX
IPC: F02G1/00
Filed: 1993-11-30
Abstract: PCT No. PCT/GB93/02472 Sec. 371 Date Jun. 1, 1995 Sec. 102(e) Date Jun. 1, 1995 PCT Filed Dec. 1, 1993 PCT Pub. No. WO94/12785 PCT Pub. Date Jun. 9, 1994An internal combustion engine has a compression cylinder with a liquid spray apparatus for spraying sufficient liquid into the cylinder such that the liquid absorbs the heat of the gas as it is compressed without vaporizing. A separator removes the liquid from the gas/liquid mixture as it leaves the cylinder. The gas is then directed to a expansion cylinder for combustion with fuel delivered by a fuel supply apparatus. The cylinders being coupled together by a crankshaft.
Patent MX-340699-B (MX)
Title: Printing process with metallised effect over non-cellulosic or plastic substrates.
Inventor: DELFINO GIL JUNGMANN
IPC: B41M3/00
Filed: 2010-02-04
Abstract: The inventive process refers to the addition of a metallised print (1) specifying the areas where the metallic effect is to be obtained (2) and differentiating the areas blocked with white ink so that they are not provided with said metallic effect (3) but only with the selected colours. Said information is directly sent from a computer (4) to the equipment intended to prepare the printing plates, (5) which are five for obtaining four colours selected from yellow, magenta, cyan and black, and white (6) which is used for blocking the non-metallised areas, the printing process and the materials used for achieving said effect are: pvc, pet, polypropylene, lentil material or any other transparent material which thickness is not higher than 1mm. This printing process requires hybrid equipments having a double hybrid varnish tower which may carry out the printing with UV inks, and which include UV drying lamps for curing the ink, this printing process (7), (13) including the application of the metallised film, which may be thermal o water-based (16), the film being applied on the print area, thus achieving the desired effect, (17) which may be silver-plated, hologram, iridescent or gold-coloured.
Patent MX-341075-B (MX)
Title: Surgical needle coatings and methods.
Inventor: MAURER ROBERT
IPC: A61M5/32
Filed: 2010-10-21
Abstract: The present invention provides improved medical devices for use in surgical procedures and methods for manufacturing improved medical devices. In some embodiments, the improved medical devices can include improved surgical needles that arc capable of being repeatedly passed through tissue using minimal force. More particularly, the improved surgical needles can be manufactured with two or more different coatings that provide the surgical needles with both durability and lubricity for ease of repeated and successive passes through tissue. Improved methods for manufacturing the surgical needles and for providing and applying coatings to the surgical needles are also provided.
Patent MX-338584-B (MX)
Title: Gel- based compositions and method of making same.
Inventor: SRIDHAR VIDYA
IPC: A23L29/231
Filed: 2011-01-18
Abstract: A gel-based comestible and method of preparing same. In one embodiment of the invention, the gel-based comestible is consumed in one bite without the need for a spoon or other utensil, and supplies the consumer with about 200 mg/serving caffeine, 1000 mg/serving taurine, and 100% of the recommended daily allowances of vitamins B3, B5, B6 and B12.
Patent MX-340880-B (MX)
Title: Improved vaccines and methods for using the same.
Inventor: DAVID B WEINER
IPC: A61K39/00
Filed: 2009-01-28
Abstract: Improved anti-HlV imm nogens and nucleic acid molecules that encode them are disclosed, lmmunogens disclosed include those having consensus sequences for HIV Subtype A Envelope protein, those having consensus sequences for HlV Subtype B Envelope protein, those having consensus sequences for HIV Subtype C Envelope protein, those having consensus sequences for HIV Subtype D Envelope protein, those having consensus sequences for HIV Subtype B consensus Nef-Rev protein, and those having consensus sequences form HIV Gag protein subtypes A, B, C and D. Improved anti-HPV immunogens and nucleic acid molecules that encode them; improved anti-HCV immunogens and nucleic acid molecules that encode them; improved hTERT immunogens and nucleic acid molecules that encode them; and improved anti-Influenza immunogens and nucleic acid molecules that encode them are disclosed. Pharmaceutical composition, recombinant vaccines comprising and live attenuated pathogens are disclosed as well methods of inducing an immune response in an individual against HIV, HPV, HCV, hTERT and Influenza are disclosed.
Patent MX-367075-B (MX)
Title: Human antibodies to pcsk9 for use in methods of treating particular groups of subjects.
Inventor: CORINNE HANOTIN
IPC: A61P9/10
Filed: 2012-01-27
Abstract: The present invention relates to methods for treating diseases or conditions in which proprotein convertase subtilisin/kexin type 9 (PCSK9) expression or activity causes an impact by administration of PCSK9-specific antibodies or antigen-binding fragments thereof and preferably by additional administration of an inhibitor of 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMG-CoA reductase). The present invention further relates to PCSK9-specific antibodies or antigen-binding fragments thereof for use in the treatment of diseases or conditions in which PCSK9 expression or activity causes an impact. The present invention also relates to articles of manufacture comprising packaging material, PCSK9-specific antibodies or antigen-binding fragments thereof, and a label or packaging insert indicating which groups of patients can be treated with said antibodies or fragments, which groups of patients must not be treated with said antibodies or fragments, and which dosage regimen should be used. The present invention further relates to methods of testing the efficacy of PCSK9-specific antibodies or antigen-binding fragments thereof for the treatment of certain diseases or conditions and for the treatment of specific sub-groups of patients.
Patent MX-359947-B (MX)
Title: Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen.
Inventor: AARON DEYKIN
IPC: A61K38/21
Filed: 2012-03-15
Abstract: The present invention provides a method for treating multiple sclerosis (MS), and for reducing flu-like symptoms associated with administration of an interferon to a patient with MS. The method involves intramuscularly administering the interferon to the MS patient according to an escalating dosing regimen in weeks 1 to 3, and a full therapeutically effective dose of interferon in week 4. In one embodiment of the invention, the escalating dosing regimen comprises administering one quarter of the therapeutically effective dose in week 1, half of the therapeutically effective dose in week 2, and three-quarters of the therapeutically effective dose in week 3. Also provided are titration packages for enabling compliance with a regimen of changing dosage of an interferon over a period of time.
Patent MX-367779-B (MX)
Title: Method for obtaining superparamagnetic hybrid nanostructures with drugs and the use thereof as antineoplastic agent controlled and steered by magnetic fields.
Inventor: JESUS ALBERTO GOMEZ TREVIÑO
IPC: A61K9/14
Filed: 2013-10-04
Abstract: The invention consists in a method for obtaining superparamagnetic hybrid nanostructures with drugs and the use thereof as antineoplastic agent controlled and steered by magnetic fields. The method consists of the following steps: synthesis of superparamagnetic nanoparticles coated with an organic acid; coating of the particles of supermagnetic magnetite with organic acid (MSF) with an hydrophobic antineoplastic drug; stabilization of the superparamagnetic magnetite particles coated with the drug (MCF) by means of coatings with molecules of non-ionic triblock copolymers; purification of the precipitated solid, and storage of the superparamagnetic hybrid nanostructures with the drug (MCFP). Said superparamagnetic hybrid nanostructures with the drug can be steered and located in a specific place of the human being by means of the application of exciting magnetic fields, thus enabling the cytotoxic active principle to be locally supplied in neoplastic tissues, thus solving an important p roblem of drugs with antineoplastic activity such as hydrophobicity and low bioavailability.
Patent MX-356095-B (MX)
Title: Methods of manufacturing wire, wire pre-products and wires.
Inventor: FREDERICK J KELLEY
IPC: B29C48/885
Filed: 2012-04-03
Abstract: Exemplary methods for manufacturing a wire and resultant wires are disclosed herein. The method includes extruding a cross-linkable polymer that is substantially free of curing agent about a conductive core, then adding a curing agent to the extruded wire pre-product, then heat-curing the extruded wire pre-product.
Patent MX-364876-B (MX)
Title: System and method for performing a hybrid simulation of a medical procedure.
Inventor: OFER THALER
IPC: G09B23/00
Filed: 2012-04-30
Abstract: Embodiments of the invention are directed to a method of performing a simulation of a medical procedure. A physical model of an anatomical structure and of a medical tool may be provided. 3D digital models of the anatomical structure and medical tool may be provided. A location parameter related to a location of the physical medical tool with respect to the physical model of the anatomical structure may be received. The 3D models of the anatomical structure and medical tool may be manipulated according to the location parameter.
Patent MX-341197-B (MX)
Title: 5-substituted isoindoline compounds.
Inventor: GEORGE W MULLER
IPC: C07D401/14
Filed: 2009-05-28
Abstract: This invention relates to 5-substituted isoindoline compounds, and pharmaceutically acceptable salts, solvates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.
Patent MX-335997-B (MX)
Title: Keying for mpo systems.
Inventor: EBERLE JAMES JOSEPH JR
IPC: G02B6/36
Filed: 2013-02-28
Abstract: Keying may be used to indicate various features of cables, cable connectors, and/or equipment. The keying mechanisms of the connectors systems disclosed herein identifies whether each plug is a pinned plug or a pinless plug. The keying mechanisms disclosed herein identify the number of optical fibers terminated at each plug. For example, one type of keying mechanism may indicate a cable plug manufactured under a 40 Gb/sec standard and another type of keying mechanism may indicate a cable plug manufactured under a 100 Gb/sec standard. The keying mechanisms may indicate a cabling/wiring pattern to be used (e.g., indicates a polarity of the cable). The cables and/or plugs may be color coded based on the keying mechanism. Accordingly, the keying may alert a user to the features of the cable that are not readily apparent upon a cursory inspection.
Patent MX-350921-B (MX)
Title: Method for producing dithiine tetracarboximides.
Inventor: HIMMLER THOMAS
IPC: C07D495/14
Filed: 2013-03-18
Abstract: The present invention relates to a novel method for producing dithiine tetracarboximides by reacting succinic monoamides with thionyl chloride, wherein at least one of the method steps is carried out continuously.
Patent MX-360264-B (MX)
Title: Mutational analysis of plasma dna for cancer detection.
Inventor: JIANG PEIYONG
IPC: C12Q1/6869
Filed: 2013-06-14
Abstract: A frequency of somatic mutations in a biological sample (e.g., plasma or serum) of a subject undergoing screening or monitoring for cancer, can be compared with that in the constitutional DNA of the same subject. A parameter can derived from these frequencies and used to determine a classification of a level of cancer. False positives can be filtered out by requiring any variant locus to have at least a specified number of variant sequence reads (tags), thereby providing a more accurate parameter. The relative frequencies for different variant loci can be analyzed to determine a level of heterogeneity of tumors in a patient. A frequency of somatic mutations in a biological sample (e.g., plasma or serum) of a subject undergoing screening or monitoring for cancer, can be compared with that in the constitutional DNA of the same subject. A parameter can derived from these frequencies and used to determine a classification of a level of cancer. False positives can be filtered out by requiring any variant locus to have at least a specified number of variant sequence reads (tags), thereby providing a more accurate parameter. The relative frequencies for different variant loci can be analyzed to determine a level of heterogeneity of tumors in a patient. The invention relates to an electronic lock for a door, comprising a blocking mechanism, a file transfer component, the memory interface and a programmable control circuit. Said system is also provided with a communication and data transmission interface. The blocking mechanism is coupled to the door and can move between a blocked position wherein the door cannot be opened and an unblocked position wherein the door can be opened. The file transfer component, the memory interface and the programmable control circuit are coupled to the door such that the user credentials can be validated. The programmable control circuit is coupled to the door and can be operated so as to move the blocking mechanism between the blocking position and the unblocking position at least partially according to the user reader credentials.
Patent MX-354607-B (MX)
Title: Antenna mounting systems and methods.
Inventor: DAVID MICHAEL LETTKEMAN
IPC: H01Q1/12
Filed: 2013-07-16
Abstract: An apparatus for coupling an object to a surface is disclosed. The apparatus may include a mounting plate, a mounting bracket, and a locking plate. The mounting plate may include a mounting portion configured to be coupled with the surface, a receptacle portion configured to receive a mounting bracket, and at least one protrusion extending from the mounting portion. The mounting bracket may include a backing portion, and a coupling portion. The backing portion may define at least one aperture configured to receive the at least one protrusion when the mounting bracket is disposed in the receptacle portion of the mounting plate. The coupling portion may be configured to be coupled with the object, which may be an antenna. The locking plate may be configured to be disposed between at least a portion of the at least one protrusion and at least a portion of the backing portion.
Patent MX-344082-B (MX)
Title: Methods and apparatuses for automatic provisioning of external identifiers used for machine type devices in a 3gpp network.
Inventor: ZU QIANG
IPC: H04W8/04
Filed: 2013-09-03
Abstract: In one aspect, the teachings herein propose a procedure provided by an appropriately configured 3GPP Core Network (CN), which allows External Identifiers to be provisioned dynamically by the 3GPP operator or an MTC service provider, using the existing 3GPP M2M architecture. As such, these teachings can be understood as providing for automatic activation, modification, deactivation, etc., of MTC service subscriptions or services, using protocol-based signaling between the involved entities, e.g., between a 3GPP HSS and an MTC Server (a Services Capability Server or SCS) and/or an MTC Bootstrapping Server that provides for MTC subscription activations, modifications, cancellations, etc.
Patent MX-355910-B (MX)
Title: Multi-angular color, opacity, pigment characterization and texture analysis of a painted surface via visual and/or instrumental techniques.
Inventor: PAUL MICHAEL BEYMORE
IPC: G01J3/50
Filed: 2013-09-19
Abstract: A computer implemented method. The method includes performing (73) at least one of a visual evaluation and an instrument measurement of a target coating on a target sample to generate colorimetric information, and identifying (82), using a processor, a bulk toner that is present in the target coating by determining a color and a color intensity at different viewing angles relative to the target sample. The method also includes identifying (84), using the processor, at least one specific toner that is present in the target coating by detecting a presence and an orientation of colored and/ or non- colored pigmentation effects that arc present in the target coating, and outputting (86), using the processor, a formulation of the target coating that includes at least the at least one specific toner.
Patent MX-360788-B (MX)
Title: Apparatus and method for applying an impregnating agent onto surfaces of items, in particular footwear.
Inventor: RENÉ MARKER
IPC: A43D119/00
Filed: 2014-03-03
Abstract: Apparatus for applying an impregnating agent onto surfaces of footwear at least comprising a right item and a left item, where said apparatus has a treatment chamber, where an openable and closable door is provided, said door allowing access to the interior of said treatment chamber for placing items to be impregnated inside said treatment chamber, and where adjacent the bottom of said treatment chamber means for placing the footwear at approximate determined positions are provided and where at least five nozzles are arranged in said treatment chamber, where said nozzles are able to create and issue a mist of impregnating agent, such that first and second nozzles are arranged to direct the mist to a zone of the footwear in the determined position corresponding to the front area of the right item respectively left item, and a third nozzle is positioned behind and between the determined position of the right item respectively left item, which third nozzle directs the impregnating mist towards a zone of the footwear in the determined position corresponding to the rear and inside left and right sides of the right item respectively left item, and where the fourth and fifth nozzles are arranged behind the footwear in the determined position in order to direct impregnating mist towards the rear and outside left and right sides of the right item respectively left item.